Top 35 Medical VC Funds & Investors in Portugal (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Portugal Ventures
VC Fund
|
16 | Portugal, United States, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | Software, Information Technology, Health Care | $107k–$3.6M |
|
SOSV
VC Fund
|
6 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $50k–$5M |
|
Armilar Venture Partners
VC Fund
|
5 | Portugal, United States, United Kingdom | Seed, Series A | Software, Information Technology, Artificial Intelligence | $520k–$17M |
|
Vesalius Biocapital Partners
VC Fund
|
4 | Belgium, Germany, The Netherlands | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.9M–$100M |
|
Caixa Capital
VC Fund
|
4 | Portugal, United States, Spain | Seed, Series A, Pre-Seed | Software, Information Technology, Health Care | $108k–$12M |
|
Biovance Capital
VC Fund
|
3 | Spain, Portugal, The Netherlands | Series A, Seed | Medical, Biotechnology, Pharmaceutical | $13M–$13M |
|
TheVentureCity
VC Fund
|
3 | United States, Spain, Brazil | Seed, Series A | Software, Artificial Intelligence, SaaS | $100k–$18M |
|
SOSV HAX
VC Fund
|
3 | United States, Canada, China | Seed, Convertible Note, Pre-Seed | Robotics, Manufacturing, Health Care | $25k–$4.7M |
|
ChangePartners
VC Fund
|
2 | Portugal | Seed, Series A | Medical, Biotechnology, Life Science | |
|
Critical Ventures
VC Fund
|
2 | United States, Portugal, Germany | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $1.2M–$19M |
|
EISMEA
VC Fund
|
2 | Spain, Italy, United Kingdom | Grant, Venture - Series Unknown, Seed | Manufacturing, Software, Biotechnology | $53k–$2.6M |
|
BlueCrow Capital
VC Fund
|
2 | Portugal, United Kingdom, Spain | Seed, Venture - Series Unknown, Series A | Information Technology, Manufacturing, SaaS | $697k–$18M |
|
Invicta Angels
VC Fund
|
1 | Portugal | Seed, Series A | Medical, Consulting, Life Science | |
|
Shilling VC
VC Fund
|
1 | Portugal, Spain, United States | Seed, Pre-Seed, Series A | Information Technology, Software, Artificial Intelligence | $125k–$20M |
|
Olisipo Way
VC Fund
|
1 | Portugal, Germany, Lithuania | Seed, Pre-Seed, Venture - Series Unknown | Software, Information Technology, Analytics | $118k–$5.3M |
|
3xP Global
VC Fund
|
1 | Portugal, Spain, France | Private Equity, Seed, Venture - Series Unknown | Information Technology, Health Care, Software | $881k–$3.6M |
|
2bpartner Sociedade de Capital de Risco S.A.
VC Fund
|
1 | Portugal, Spain | Seed, Series A | Software, Apps, Mobile | $56k–$482k |
|
Green Innovations
VC Fund
|
1 | Portugal, United States | Seed, Series A | Pet, Medical, Genetics | |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
1 | Germany, Switzerland, United States | Seed, Series A, Pre-Seed | Software, Biotechnology, Information Technology | $790k–$31M |
|
Iberis Capital
VC Fund
|
1 | Portugal, United States, Spain | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $107k–$23M |
|
Alpha Venture
VC Fund
|
1 | Italy, Portugal, Switzerland | Pre-Seed, Angel | SaaS, Artificial Intelligence, Software | $155k–$1.9M |
|
Torrey Pines Investment
VC Fund
|
1 | United States, Russian Federation, The Netherlands | Seed, Pre-Seed | Biotechnology, Health Care, Pharmaceutical | $3M–$3.1M |
|
Vento
VC Fund
|
1 | Italy, United Kingdom, Switzerland | Pre-Seed, Seed, Angel | Artificial Intelligence, Software, SaaS | $544k–$13M |
|
Growth Engine
VC Fund
|
1 | Italy, Mexico, Portugal | Seed, Secondary Market, Pre-Seed | E-Commerce, Software, Artificial Intelligence | $300k–$4.2M |
|
Artesian VC
VC Fund
|
1 | Australia, United States, China | Seed, Venture - Series Unknown, Pre-Seed | Software, Health Care, Artificial Intelligence | $40k–$17M |
|
Social Impact Fund
VC Fund
|
1 | Spain, Portugal, United States | Debt Financing, Seed | Software, Education, Apps | $995k–$5.7M |
|
AngelsWay
VC Fund
|
1 | Portugal | Seed | E-Commerce, Health Care, Artificial Intelligence | $57k–$704k |
|
COREangels
VC Fund
|
1 | Spain, United States, Portugal | Seed, Pre-Seed, Series A | Software, Information Technology, Health Care | $124k–$17M |
|
Explorer Investments
VC Fund
|
1 | Portugal, Spain, Brazil | Private Equity, Seed, Venture - Series Unknown | Manufacturing, Information Technology, Retail | $1.7M–$21M |
|
Lince Capital
VC Fund
|
1 | Portugal, United Kingdom, United States | Seed, Venture - Series Unknown, Series A | Artificial Intelligence, Hospitality, E-Commerce | $859k–$16M |
|
FSNB Health & Care
VC Fund
|
1 | ||||
|
Demium Capital
VC Fund
|
1 | Spain, Portugal, Poland | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | $110k–$3.1M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
1 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
OrbiMed
VC Fund
|
1 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $9M–$160M |
|
The Techshop
VC Fund
|
1 | Italy, Portugal, Switzerland | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, FinTech | $322k–$120M |
| Access all 65 VC funds in Portugal Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Verticals:Enterprise, SaaS, Security, Networks, AI, VR/AR, Marketplace, Blockchain, Internet of Things, New materials, Electronics, Robotics, Cleantech, Agrotech, Seatech, Therapeutics, Digital Health, Diagnostics, Innovative Accommodation, Tourist Entertainment Companies, Tour Operators, Wine, Nautical and Equestrian Tourism, Theme Parks Mobile, Robotics Founded in 2012, Portugal Ventures is a venture capital firm based in Porto, Portugal. The firm is a part of the Banco Português de Fomento group. The firm seeks to invest in pre-seed, seed and series A stages
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 389
- Round size: Seed $121k–$1.9M; Pre-Seed $107k–$796k; Venture - Series Unknown $121k–$3.6M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Aptoide — Find, discover and download the best apps and games for Android in the official Aptoide app store
- Unlockit — Unlockit will offer to public and governmental bodies the guarantee that everything within a real estate transaction is recorded, meaning better industry regulation, more taxes and public fees collected, and less overall fraud and money laundering activities.
- Outgoing — A ticketing tool that allows organizers to sell tickets directly on WhatsApp and Instagram. Users can purchase tickets through a personalized checkout process entirely within the chat, without registration or redirects. It also offers customer support that answers questions in real time.
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3729
- Round size: Seed $150k–$5M; Pre-Seed $50k–$1.6M; Convertible Note $50k–$3.6M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Simply Good Jars — Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everydayoperations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
Armilar Venture Partners is Portugal's leading venture capitalist. An independent VC with a 20-year-old history, a high-performance track record and an international footprint, Armilar is a deep-tech investor in ICT, HealthTech and CleanTech.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 119
- Round size: Seed $520k–$3.9M; Series A $4M–$17M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely actively investing — fresh fund, raised $138M in 2025
Portfolio highlights
- FRANK — FRANK provides an AI assistant software platform designed to automate routine, administrative back-office tasks for insurance agents and brokerages. The platform integrates directly with client communication channels (such as email and WhatsApp) and insurer portals to handle document processing, task execution, and fast quoting.
- Neuraspace — Focus on fewer alerts with more time to manoeuver, with a scalable AI/ML solution from Neuraspace
- Usawa Care — Usawa is a free digital pediatrician clinic in Portugal. Talk to pediatricians via WhatsApp and get guidance for your child's health.
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception. With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financing rounds. Their companies are based in Europe allowing easy interaction with management. They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Belgium, Germany, The Netherlands
Investor stats
- Total investments: 62
- Round size: Series A $3.9M–$31M; Series B $4.4M–$26M; Series C $7.8M–$100M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $103M in 2023
Portfolio highlights
- Nutrium — Nutrium is the most up-to-date nutrition software for dietitians and nutritionists to manage their nutrition business with nutritional assessment, meal planning and progress tracking.
- RougeTx — RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding.
- ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
Caixa Capital is the Private Equity and Venture Capital arm of banking Group Caixa Geral de Depósitos and has a track record spanning over two decades of activity, since the industry was created in Portugal. It is a leading investor in terms of funds under management, portfolio size and diversity. Caixa Capital´s mission is to invest in funds and companies, led by highly qualified management teams, with high growth and valuation potential, that enable our funds to achieve an attractive risk adjusted return and for society at large to benefit sustainably from our activity. Currently with more than 700 million Euros under management and a portfolio of over 80 investments, Caixa Capital is a reference in this area with special links to the respective European sector associations.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Portugal, United States, Spain
Investor stats
- Total investments: 90
- Round size: Seed $111k–$3M; Pre-Seed $108k–$1.7M; Series A $3M–$12M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Growappy — Growappy is an EdTech that offers an all-in-one platform for early education that is leading a vision to unlock personalized education since nursery with the power of AI, while providing a revolutionary communication experience between schools and families and drastically simplifying bureaucracy for teachers and school owners.
- Noxus — At Spot, we're crafting the operating system for tomorrow's workforce, harnessing AI to streamline influencer marketing. Our platform empowers agencies, businesses, and content creators to collaborate effectively and reach audiences with ease.
- Infraspeak — Infraspeak is an Intelligent CMMS Software that brings outstanding flexibility, connectivity and intelligence to your operations.
Biovance Capital is a new € 51M fund to invest in early-stage biotech companies across Europe developing innovative therapeutics in all disease areas and drug modalities (small and large molecules, vaccines, cell, and gene therapies).
Show more...Investment focus
- Industry: Medical, Biotechnology, Pharmaceutical
- Stage:Series A, Seed
- Geography: Spain, Portugal, The Netherlands
Investor stats
- Total investments: 6
- Round size: Series A $13M–$13M
- Lead/follow: 100% lead, 0% follow
- Last fund: Likely still investing — raised $55M in 2024
Portfolio highlights
- Vaxdyn — Preventing the next global health crisis Our mission is to prevent and alleviate the global health crisis caused by the pathogenic bacteria resistant to ant ...
- Laigo Bio — Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders.
- Mondego Bio — Mondego Bio is developing best-in-class PTPN2 inhibitors to advance breakthrough cancer immunotherapies with improved safety, tolerability, and efficacy.
TheVentureCity is an early-stage venture capital fund working alongside tech founders redefining fundamental industries. Managing over $150M, the fund leads Seed and Series A rounds of $2.5M to $4M across the United States, Europe and Latin America. We invest in companies across fintech, healthtech and mobility & logistics, where proprietary data, AI and automation are core to building defensible products.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A
- Geography: United States, Spain, Brazil
Investor stats
- Total investments: 173
- Round size: Seed $100k–$4.9M; Series A $2.3M–$18M
- Lead/follow: 13% lead, 87% follow
- Last fund: Likely actively investing — fresh fund, raised $2.8M in 2026
Portfolio highlights
- Belo — Crypto for everyone, everyday
- Senticell — Senticell is a biotechnology and molecular diagnostics company developing a breakthrough platform that uses red blood cell (RBC) DNA and cfDNA analysis to revolutionize non-invasive disease detection. The research demonstrates that RBCs act as immune-responsive biosensors, capable of carrying molecular and genetic biomarkers from across the body -unlocking a powerful and previously untapped gateway for liquid biopsy and precision diagnostics. By harnessing this cellular intelligence, we enable early disease detection, biomarker discovery and AI-driven diagnostic insights to support precision medicine and personalised treatment outcomes.
- Tiny Health — Tiny Health is the first at-home gut health test for moms and babies 0-3 years. Detect any gut imbalances early on and prevent chronic conditions.
HAX is a program for Hard Tech startups taking their first steps towards commercialization. We provide hands-on support and investment as part of SOSV, a $1B AUM multi-stage venture firm.
Show more...Investment focus
- Industry: Robotics, Manufacturing, Health Care
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, Canada, China
Investor stats
- Total investments: 669
- Round size: Seed $100k–$4.7M; Pre-Seed $25k–$2.4M; Convertible Note $100k–$3.8M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- 5QXT — 5QXT is a mining technology company that provides the design, development, and implementation of metal extraction processes.
- XFuel — XFuel is a fuel company that provides green and clean fuels to distributors and consumers. The company was founded in 2010 and is based in Palma de Mallorca, Baleares.
- Cortysis — Cortysis develops brain stimulation device for rapid spatial and temporal modulation of cortical networks
ChangePartners is an independent company dedicated to mid-size transactions in the Iberian market. They develop high value added solutions specific to each particular situation , offering a fair and unbiased opinion. Their independence guarantees no conflicts of interest. Their small size and focus ensures full dedication to each transaction.
Show more...Investment focus
- Industry: Medical, Biotechnology, Life Science
- Stage:Seed, Series A
- Geography: Portugal
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Exogenus Therapeutics — Exogenus Therapeutics is engineering cell biology for innovative therapeutic solutions.Exo-T is a biotechnology company dedicated to the pre-clinical and clinical development of innovative cellular-based therapies applied to regenerative medicine, specifically for the skin lesions treatment. The company is presently developing its first product,Exo-Wound, for the treatment of chronic wounds.The project that led to the creation of the company (Nanoinspire) participated in COHiTEC 2014 program and is the result of the research developed in collaboration with Crioestaminal SA, Biocant, and Centre for Neurosciences and Cellular Biology of Coimbra University.
- Biomode — Biomode is a startup venture based in Caldas das Taipas (Portugal) that aims to be a leading provider of rapid and accurate molecular diagnostic tests for identification of pathogens in the food, environment and life science industries.Biomode’s diagnostic kits are based on the PNA-FISH (Peptide Nucleic Acid Fluorescence In Situ Hybridisation)technology.Biomode’s founders are a group of researchers from the universities of Minho and Porto (Portugal) that is one of the few worldwide research groups with the skills to design PNA-FISH probes targeting specific pathogens.Biomode will enter the food industry diagnostics market with a kit for detecting Salmonella in food samples (Probe4Salmonella®) soon to be followed by two other kits for the detection of Listeria monocytogenes and E. coli O157:H7. On the clinical diagnostics area, Biomode has already developed a kit aimed at the rapid identification of clarithromycin resistance of H. Pylori strains (Probe4Pylori®) that is in the process of obtaining investigational device exemption from the Food and Drug Administration (FDA) in order to undergo field trials.
Critical Ventures is venture capital arm of Critical Group. It partners with the most inspiring and courageous entrepreneurs developing innovative technologies with the potential to disrupt global markets.It is designed to support entrepreneurs from an early stage, with expertise, strategic guidance and a unique ecosystem of technologybusinesses, helping to build companies that are future pioneers with the ability to shape new markets.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Portugal, Germany
Investor stats
- Total investments: 9
- Round size: Seed $1.2M–$13M; Series A $2.8M–$19M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2011
Portfolio highlights
- Almetra — We use computer vision and AI analytics to provide insights into manual assembly processes - our platform supports process engineers in driving productivity and quality of assembly processes
- Humanos — Humanos helps companies measure, control and transfer AI risk through continuous Risk Intelligence, unlocking insurance, credit, yield and other financial products.
- RunSafe Security — Secure embedded systems with RunSafe Security's runtime cybersecurity protection, integrating build-time defenses without affecting performance.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!EISMEA is an executive agency of the European Commission that implements European Union programs supporting innovation, small and medium-sized enterprises, and the Single Market. The agency manages the European Innovation Council and European Innovation Ecosystems programs under Horizon Europe. It also implements the SME component of the Single Market Programme and the Interregional Innovation Investments instrument. EISMEA provides funding and support for innovators, researchers, businesses, regions, and other organizations through grants, procurement, investment, and advisory programs. Its activities cover innovation development, SME competitiveness, entrepreneurship, market access, consumer policy, standardization, and interregional innovation. The agency also supports the implementation of EU policies and programs related to innovation ecosystems and economic development.
Show more...Investment focus
- Industry: Manufacturing, Software, Biotechnology
- Stage:Grant, Venture - Series Unknown, Seed
- Geography: Spain, Italy, United Kingdom
Investor stats
- Total investments: 3546
- Round size: Seed $53k–$800k; Grant $54k–$2M; Venture - Series Unknown $573k–$2.6M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
- Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
BlueCrow Capital is a venture capital firm.
Show more...Investment focus
- Industry: Information Technology, Manufacturing, SaaS
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Portugal, United Kingdom, Spain
Investor stats
- Total investments: 32
- Round size: Seed $697k–$10M; Series A $6.5M–$16M; Venture - Series Unknown $3M–$18M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Bighub — The All-in-One Platform for european marketplace growth. Integration, Catalog SEO, Pricing, Financing, Logistics, Helpdesk, and Resale.
- Flowbotic — development and manufacturing of AGVs and AMRs
- Bling Energy — Bling Energy is a startup that focuses on providing more efficient and sustainable energy solutions, mostly through solar panels.
Invicta Angels - Business Angels Association of Porto (www.invictaangels.pt), is a club which congregates 50 business angels from the Porto region. Invicta Angels is co-founder of FNABA (www.fnaba.org). In the last years they have made several investments in startups, either alone or as a joint venture with other clubs and venture capital funds.Some of the companies in which they have made investments, have already a global focus in their target markets, and are exceeding their initial expectations in revenue generation from overseas. Having this in mind, they intend to periodically inform on their business portfolio their international business partners, business angels and venture capital funds, with whom they have established relations through EBAN (www.eban.org) in Europe, or ACA (www.angelcapitalassociation.org) in the USA.Invicta Angels represents 50 investors, entrepreneurs and senior executives of companies, with extensive experience in business and strong relationships with entrepreneurship through the creation, management and investment companies.
Show more...Investment focus
- Industry: Medical, Consulting, Life Science
- Stage:Seed, Series A
- Geography: Portugal
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OmniumAI — OmniumAI are developing CibusAI to revolutionise traditional food reformulation.
- Biomode — Biomode is a startup venture based in Caldas das Taipas (Portugal) that aims to be a leading provider of rapid and accurate molecular diagnostic tests for identification of pathogens in the food, environment and life science industries.Biomode’s diagnostic kits are based on the PNA-FISH (Peptide Nucleic Acid Fluorescence In Situ Hybridisation)technology.Biomode’s founders are a group of researchers from the universities of Minho and Porto (Portugal) that is one of the few worldwide research groups with the skills to design PNA-FISH probes targeting specific pathogens.Biomode will enter the food industry diagnostics market with a kit for detecting Salmonella in food samples (Probe4Salmonella®) soon to be followed by two other kits for the detection of Listeria monocytogenes and E. coli O157:H7. On the clinical diagnostics area, Biomode has already developed a kit aimed at the rapid identification of clarithromycin resistance of H. Pylori strains (Probe4Pylori®) that is in the process of obtaining investigational device exemption from the Food and Drug Administration (FDA) in order to undergo field trials.
Shilling is an early-stage venture capital firm backing exceptional founders from the start. Shilling invests in a wide range of verticals and seeks out the biggest opportunities across all B2B and consumer categories. Leveraging the concept of Founder LPs, Shilling brings much more than capital and offers through its Shilling Platform, direct access to successful founders and executives of leading companies. This platform supports entrepreneurs in validating and developing their ventures, which then accelerate their growth into global markets.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, Spain, United States
Investor stats
- Total investments: 119
- Round size: Seed $274k–$5M; Pre-Seed $125k–$3M; Series A $5M–$20M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely still investing — raised $49M in 2024
Portfolio highlights
- Tucuvi — Tucuvi is a health technology company unlocking efficient and high-quality healthcare at scale with a CE-marked platform for Phone Consultation Automation. We develop safe and clinically validated Conversational AI for any care pathway, enabling clinical teams to augment their capacities, improve processes’ efficiency and efficacy, and achievebetter patient outcomes and satisfaction through continuous and personalized care.
- Balance — Balance is a private digital health company based in Spain that operates in the clinics and outpatient healthcare services sector. company's core mission is to provide an integrated, medical, and sustainable approach to treating obesity and overweight conditions. Moving away from traditional restrictive diets, the company leverages asubscription-based telehealth model combined with clinical pharmacology.
- Punto Health — Help healthcare and care teams deliver personalised daily support, with cognitive insights and professional monitoring to inform ongoing care.
Olisipo Way is an early-stage venture firm that focuses on IT investments. It invests in technology companies with very diverse and complementary skills. The initial portfolio of Olisipo Way comes from the innovation created within the Olisipo through the continuous stimulation of innovation among employees and the incubation of new businessventures.The firm was founded in 2015 and is headquartered in Lisbon, Lisboa.
Show more...Investment focus
- Industry: Software, Information Technology, Analytics
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Portugal, Germany, Lithuania
Investor stats
- Total investments: 44
- Round size: Seed $250k–$5.3M; Pre-Seed $118k–$1.5M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- DoJob.ai — Hybrid Intelligence Innovation Project
- OSCAR — OSCAR offers a variety of fixed-price home services, including maintenance, cleaning, laundry, and beauty services, all accessible through a user-friendly app. Customers can easily schedule appointments for these services, with options available for immediate bookings. Additionally, OSCAR provides repair services for household appliances likewashing machines and boilers, ensuring convenience for users. The platform streamlines the process of finding and scheduling necessary home services, catering to the needs of busy individuals and families. Through its comprehensive service offerings, OSCAR simplifies home management for its users.
- Fluxe Insurance Software — Fluxe develops a wide range of digital tools, cyber security, blockchain, and AI software for the insurance industry.
3XP Global is an Asset Management firm with a distinct track record in terms of ESG Integration in the Investment Process and an Active Role in helping founders throughout the investment cycle.
Show more...Investment focus
- Industry: Information Technology, Health Care, Software
- Stage:Private Equity, Seed, Venture - Series Unknown
- Geography: Portugal, Spain, France
Investor stats
- Total investments: 17
- Round size: Seed $881k–$3.6M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Amparo — We empower amputees so they can live life to the full. Amparo is a developer, manufacturer and distributor of prosthetic components. It developed the Confidence Socket, which is the interface between the patient's residual limb and the prosthetic leg itself. 1) The fitting process is as fast as 1h time; 2) The material can be remolded 10times, saving huge costs of health providers; and 3) All tools fit into a sports bag. making it possible to service amputee anywhere in the world.
- ECO-ONE — ECO-ONE provides sustainability and circular economy solutions for the hotel sector.
- BloodFlow — BloodFlow is the invisible layer of clinical intelligence embedded in every EMR, continuously augmenting clinicians with real-time, context-aware medical insight.
2bpartner is a venture capital company with a highly skilled management team that can not only raise the necessary capital for your business implementation but also help you with management expertise and business network in order to maximize your performance. 2bpartner was created in 2007 by AIminho and several private investors and companies. In the end of 2011 the Minho Inovação e Internacionalização fund was created and in 2012 dst group became the majority shareholder of 2bpartner’s capital. They are currently seeking for ambitious entrepreneurs and management teams that need funds to grow their companies, projects and ideas with great potential for global expansion and value creation.
Show more...Investment focus
- Industry: Software, Apps, Mobile
- Stage:Seed, Series A
- Geography: Portugal, Spain
Investor stats
- Total investments: 5
- Round size: Seed $56k–$482k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Watt IS — Watt-IS is a data analytics startup company focused on delivering energy efficiency to households and small and medium-sized enterprises (SMEs). Through the development of intelligent and self-learning data analytics tools, along with user engagement platforms, we aim to increase user satisfaction levels, reduce churn rates and deliver new revenuestreams to energy utilities and Energy Service Companies (ESCO’s). Based on our data analytics and energy efficiency skills, we can provide finer customer segmentation, evaluation of Demand Side Flexibility potential and better tailor specific value-added services that can foster new sources of income for energy utilities.
- TOPDOX — TOP Docs designs and develops document collaboration tools for mobiles and the web.The company offers a multi-cloud office platform that allows users from various clouds to collaborate on MS Word documents, Open Office, and Google Docs. It also enables its users to write, edit, collaborate, share, search, access, read, copy, move, and organizedocuments.TOP DOCS was founded on April 10, 2014, and is based in Porto, Portugal.
- Biomode — Biomode is a startup venture based in Caldas das Taipas (Portugal) that aims to be a leading provider of rapid and accurate molecular diagnostic tests for identification of pathogens in the food, environment and life science industries.Biomode’s diagnostic kits are based on the PNA-FISH (Peptide Nucleic Acid Fluorescence In Situ Hybridisation)technology.Biomode’s founders are a group of researchers from the universities of Minho and Porto (Portugal) that is one of the few worldwide research groups with the skills to design PNA-FISH probes targeting specific pathogens.Biomode will enter the food industry diagnostics market with a kit for detecting Salmonella in food samples (Probe4Salmonella®) soon to be followed by two other kits for the detection of Listeria monocytogenes and E. coli O157:H7. On the clinical diagnostics area, Biomode has already developed a kit aimed at the rapid identification of clarithromycin resistance of H. Pylori strains (Probe4Pylori®) that is in the process of obtaining investigational device exemption from the Food and Drug Administration (FDA) in order to undergo field trials.
International, Life Sciences, Biotechnology
Show more...Investment focus
- Industry: Pet, Medical, Genetics
- Stage:Seed, Series A
- Geography: Portugal, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Findster — Findster is a pet tech company that provides peace of mind to pet owners by helping them keep track of their pet's location and well-being 24/7. In 2016, Findster introduced the first GPS tracker to allow true real-time monitoring and to not require monthly fees - Findster Duo - via a $250k Kickstarter campaign. The company has sincebecome one of the fastest growing pet tech companies in the world, with the Duo currently being the #1 Best Seller in its category on Amazon.com and used in over 80 countries on a daily basis.At the core of Findster is Maze®, a proprietary technology platform that allows IoT systems to communicate in real-time, off-grid, in a long-range without being dependent on the cellular infrastructure from Telcos.
- CBR Genomics — We apply our end-to-end solutions to hand genetic reports at the clinical desk. We make Genomics accessible!
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in various sectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 781
- Round size: Seed $790k–$6.9M; Pre-Seed $841k–$2.8M; Series A $3M–$31M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $515M in 2022
Portfolio highlights
- Selfapy — Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.
- Smartblue — Smartblue develops and runs software and processes to monitor and optimize zero emission energy systems. As a hardware independent specialist Smartblue delivers a software service for the maintenance, life-cycle management, production forecasting and remote control of photovoltaic and energy storage systems all together in one centralized “SmartControl” Operations and Control Center web application. We help our customers drive down overall operational cost through automation, smart failure detection and big data analysis on imminent defects.
- OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Iberis is a leading venture capital fund manager in Portugal, overseeing more than 600M EUR and investing in innovative technology startups.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Portugal, United States, Spain
Investor stats
- Total investments: 63
- Round size: Seed $1.2M–$4.6M; Pre-Seed $107k–$4.4M; Series A $5.3M–$23M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Tryp.com — Cheap trips and travel deals to destinations worldwide. Compare top offers, discover new places and grab the best price on your next getaway.
- Reckon.ai — Whether you're building an unattended store or supplying the equipment behind it, Reckon's patented AI technology transforms existing infrastructure into smart, autonomous assets.
- Jscrambler — Jscrambler is the leading client-side security solution for JavaScript in-app protection and real-time webpage monitoring. Start your free trial today!
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Alpha Ventures | We are the first money into your startup
Show more...Investment focus
- Industry: SaaS, Artificial Intelligence, Software
- Stage:Pre-Seed, Angel
- Geography: Italy, Portugal, Switzerland
Investor stats
- Total investments: 6
- Round size: Pre-Seed $155k–$1.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CiaoDott — Automatizza le telefonate, prenotazioni e FAQ del tuo studio medico con CiaoDott, l'assistente vocale AI disponibile 24/7. Provalo gratis.
- Navifare — Navifare is an AI-powered travel price optimization and metasearch platform that focuses on flight, hotel, and car rental price comparison. The platform analyzes flight offers users already found and searches for lower fares from online travel agencies and airlines. Users can upload screenshots, paste flight details, or use a Chrome extension thatoverlays a “Find Better Fare” button on major booking sites. Navifare exposes its price discovery capabilities via a web app, a REST API, and an MCP server for integration into AI assistants. It redirects users to partner sites to complete bookings and does not handle payments directly.
- Qura — Qura ti aiuta a prevenire oggi quello che potresti curare domani. Check-up completo, medico dedicato e protocollo personalizzato.
Torrey Pines Investment, founded in 2002, is a specialty life-science investment company located in San Diego. Torrey Pines has a team of investment professionals with extensive experience in entrepreneurship, venture capital and operations. Our firm has created biopharma incubators investing in early development stage assets from international pharma and biotech partners in CNS, oncology, and virology areas to bring them to commercial success through pharma partnering and M&A. We are committed to capitalizing on the unique opportunities in biotech and pharma, where we can add value in development or regulatory strategy by utilizing resources of our portfolio CRO companies. We seek to leverage our industry knowledge, network of industry and financial contacts, and internal resources to assist our portfolio management in developing and executing their business strategy. Our bottom line is to help our companies achieve growth, build value and realize wealth.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: United States, Russian Federation, The Netherlands
Investor stats
- Total investments: 33
- Round size: Seed $3M–$3.1M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $60M in 2017
Portfolio highlights
- Mondego Bio — Mondego Bio is developing best-in-class PTPN2 inhibitors to advance breakthrough cancer immunotherapies with improved safety, tolerability, and efficacy.
- BIMINI Biotech — BIMINI Biotech is a startup that develops innovative therapeutic strategies for oncology. It is developing therapeutic strategies that target the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases, and aging.The company was founded in 2019 and is based in Leiden, TheNetherlands.
- Mair Therapeutics — Mair Therapeutics main goal is finding and creating a small-molecule ion channel activator to treat Parkinson's disease, a preclinical drug discovery business.
We want to empower the next generation of exceptional Italian founders by investing in and building new companies.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, SaaS
- Stage:Pre-Seed, Seed, Angel
- Geography: Italy, United Kingdom, Switzerland
Investor stats
- Total investments: 56
- Round size: Seed $1.1M–$13M; Pre-Seed $544k–$3.1M
- Lead/follow: 11% lead, 89% follow
- Last fund: Likely actively investing — fresh fund, raised $82M in 2025
Portfolio highlights
- SimpL — SimpL is an Italy-based AI sales-intelligence and prospecting platform for B2B sales teams. It researches target companies, identifies relevant buying signals, drafts personalised LinkedIn outreach, manages follow-ups, and helps generate qualified sales meetings.
- Netsec — Professional cybersecurity and managed IT services to protect your business 24/7.
- Always Friday — AI Native Agency for the MICE market
Growth Engine is a sector-agnostic VC holding, investing from Pre-Seed to Pre-Series A. Thesis-driven and built on one conviction: exceptional founders win.
Show more...Investment focus
- Industry: E-Commerce, Software, Artificial Intelligence
- Stage:Seed, Secondary Market, Pre-Seed
- Geography: Italy, Mexico, Portugal
Investor stats
- Total investments: 48
- Round size: Seed $329k–$4.2M; Pre-Seed $300k–$1.7M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Holifya — Holifya offre test del DNA avanzati e piani di salute personalizzati per ottimizzare nutrizione, metabolismo, performance sportive e prevenzione. Con un unico test, scopri intolleranze, rischi genetici e strategie su misura per migliorare il benessere, tutto comodamente da casa.
- CiaoDott — Automatizza le telefonate, prenotazioni e FAQ del tuo studio medico con CiaoDott, l'assistente vocale AI disponibile 24/7. Provalo gratis.
- Vivaio Ventures — Vivaio Ventures partners with early-stage and creator-led consumer brands to scale food, beverage, and beauty products. We offer capital, consulting, and Made in Italy manufacturing excellence for the next CPG leaders.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004, Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Australia, United States, China
Investor stats
- Total investments: 643
- Round size: Seed $40k–$4.2M; Pre-Seed $42k–$553k; Venture - Series Unknown $650k–$17M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $36M in 2023
Portfolio highlights
- Vaulta — Vaulta is a battery casing technology company based in Brisbane, Australia. Using advanced composite materials and smart, streamlined design, Vaulta has developed a lighter and smaller battery case with fewer parts, creating scalable efficiencies and opportunities for manufacturers. Vaulta founder and director Dominic Spooner has over 12 yearsexperience as a design engineer, and has worked in a range of industries, including renewables and batteries, defence and aerospace, consumer products, commercial products and startups. While working in battery design, Dominic saw firsthand that opportunities for growth were being overlooked in favour of continuing with the status quo – and that’s when the idea for Vaulta was born.Vaulta’s world-first no-weld design means modules can be easily assembled and disassembled, cells reused and recycled, and new cells added as battery technology continues to evolve.From stationary storage and electric vehicles to defence, aerospace and beyond, Vaulta’s battery case technology works wherever batteries do.
- TerraBlaster — TerraBlaster is a cutting-edge agricultural technology firm focused on transforming sustainable agriculture through enhanced automation and precise technologies.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
SIF provides financial support for public charities & acts as a fiscal agent for charities and foundations.
Show more...Investment focus
- Industry: Software, Education, Apps
- Stage:Debt Financing, Seed
- Geography: Spain, Portugal, United States
Investor stats
- Total investments: 6
- Round size: Seed $995k–$2.5M; Debt Financing $1.4M–$5.7M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Irisbond — Irisbond creates a new way for humans to communicate through precision eye-tracking technology. Irisbond’s advanced software algorithms interpret your eye gaze in order to provide natural, intuitive and hands-free access to information and control over a screen. Developed for use in mobile devices, automotive, smart homes, robotics, scientific,healthcare and manufacturing, eye tracking technology lets you learn, play, work and communicate with your eyes. A pioneer in the assistive technology market, Irisbond’s eye tracking solutions are based on years of R&D in cooperation with Vicomtech, a leader in the field of artificial vision. For more information about the power of the eyes, go to www.irisbond.com/en
- tuTECHÔ — tuTECHÔ is an innovative social enterprise born with the purpose of contributing to the eradication of homelessness in Spain.
- Suara Cooperativa — Suara Cooperativa is a non-profit organization that provides education to children and youth and elder care services.
AngelsWay invests in early-stage startups based in Portugal. The company focuses on ventures that utilize technology to create a positive societal impact. AngelsWay aims to support and develop the Portuguese entrepreneurial ecosystem by building a community that brings value to all participants.
Show more...Investment focus
- Industry: E-Commerce, Health Care, Artificial Intelligence
- Stage:Seed
- Geography: Portugal
Investor stats
- Total investments: 7
- Round size: Seed $57k–$704k
- Lead/follow: 71% lead, 29% follow
Portfolio highlights
- Curiouz — Curiouz is a tech-enabled platform dedicated to source, authenticate and deliver iconic vintage furniture pieces for interior designers, collectors, and design lovers. We bring together a unique selection of items combining sustainability, craftsmanship, and technology. Discover unique items that elevate interiors.
- Coalex.ai — AI governance platform with human-in-the-loop to make deployments auditable, compliant, and self-improving. Book a demo.
- Hands On — Discover hands on workshops in Portugal! From cooking and crafts to music and photography, explore unique classes with talented local teachers.
Where startups can get much more than money, and Investors can professionally invest as angels.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Spain, United States, Portugal
Investor stats
- Total investments: 77
- Round size: Seed $278k–$5.2M; Pre-Seed $124k–$2.2M; Series A $6.1M–$17M
- Lead/follow: 9% lead, 91% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Pawer — Pawer is a digital platform that provides health and wellness services for pets, specifically designed for dogs and cats. The platform offers a range of services through its mobile application, including remote veterinary consultations, reimbursement for veterinary expenses, and discounts on pet products. It focuses on delivering accessible andcomprehensive pet care solutions, offering coverage for emergencies, regular check-ups, vaccinations, and preventive services.
- hypt — hypt is a Swiss based SaaS marketing solution that empowers companies to digitalize word-of-mouth. By using our word-of-mouth manager companies are able to activate 40% of their customers to send out a personal recommendation to their peers increasing sales through word-of-mouth by 4 times. Our solution empowers our ICP customers in the finance andinsurance segments to strategically use and optimize the most authentic and cost effective advertising channel – word-of-mouth – and makes it an accessible asset of every marketing mix.
- Ex Nunc Intelligence — Ex Nunc Intelligence provides professionals with thorough summaries of legal information, credible responses to legal issues, and automated legal document preparation features.
Founded in 2003, Explorer is Portugals leading independent management company of alternative assets, with a reputation for outstanding quality, in-depth experience and an excellent track record.
Show more...Investment focus
- Industry: Manufacturing, Information Technology, Retail
- Stage:Private Equity, Seed, Venture - Series Unknown
- Geography: Portugal, Spain, Brazil
Investor stats
- Total investments: 90
- Round size: Seed $1.7M–$11M; Venture - Series Unknown $6.6M–$21M
- Lead/follow: 60% lead, 40% follow
- Last fund: May invest from a new fund soon — raised $154M in 2018
Portfolio highlights
- Luca — Luca's learning platform provides learning programs for primary and secondary school students. The learning platform offers pre-recorded K12 videos, gamified content and AI powered personalized study paths, covering the entire official academic curriculum and national exams prep. Luca is a VC backed startup with HQ in Madrid & MexicoCity
- Neuraspace — Focus on fewer alerts with more time to manoeuver, with a scalable AI/ML solution from Neuraspace
- Spotlite — Spotlite combines satellite data with AI to predict infrastructure risks before they become problems.
Lince Capital is an independent venture capital company. Lince Capital was born from the experience of a family group with over 30 years of experience in managing investment funds in various business areas, including real estate, infrastructure, agriculture, and telecommunications.Lince Capital is distinguished by its personalized and excellentsupport, close and direct relationship with each of its investors and business partners, and the dedication of an experienced and dynamic team.
Show more...Investment focus
- Industry: Artificial Intelligence, Hospitality, E-Commerce
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Portugal, United Kingdom, United States
Investor stats
- Total investments: 57
- Round size: Seed $859k–$6.8M; Series A $2.1M–$16M; Venture - Series Unknown $1.3M–$13M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $22M in 2024
Portfolio highlights
- BIZAY — Bizay enables the world’s largest catalogue of customizable products. Its technology platform operates across Europe, South and North America, and digitalizes the booming and huge industry of product customization by empowering brands, people and societies to self-express. It enables local manufacturers, brands, and wholesalers to offercustomization on any product in the world and reduces the cost of production by half through batching and supply-chain optimization technologies. Our platform/technology is aimed at three customer targets:(i) B2B2C provides a platform for businesses to design and sell customized products from Bizay’s existing product catalogue, with the four main customer segments: Resellers, Content Creators (Independent artists, influencers or event or managers that want to sell customized merchandise with their branding, designs or artwork), e-Commerce entrepreneurs (Small entrepreneurs that aim to expand their catalogue and upgrade their business by adding customized products to their online stores), as well as big household brands & enterprises (well-established business in need of a partner that is capable of handling large volume of customized products orders or to expand their existing offer)(ii) B2B, which is focused on SMBs, provides an extensive product catalogue for customized products to be used in several industries (ex: uniforms for restaurants and bags for retail shops) (iii) Customization-as-a-Service (CaaS), where clients (typically major brands) capitalize on Bizay’s technology, expertise, customization options, techniques and offline suppliers to customize their own products
- Nutrium — Nutrium is the most up-to-date nutrition software for dietitians and nutritionists to manage their nutrition business with nutritional assessment, meal planning and progress tracking.
- Neuraspace — Focus on fewer alerts with more time to manoeuver, with a scalable AI/ML solution from Neuraspace
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Strategic Management Consulting Boutique Specialized in Healthcare / Strategy, Tactics, Organization & Public Affairs
Show more...Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Tonic App — Tonic App is a B2C2B digital health company building a professional ecosystem for medical doctors. Tonic App helps medical doctors to diagnose and treat their patients by curating, for them, in a single mobile platform, the best professional resources from peers, publishers, regulatory bodies, recruiters, providers & the industry.
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Spain, Portugal, Poland
Investor stats
- Total investments: 85
- Round size: Seed $113k–$3.1M; Pre-Seed $110k–$574k
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $59M in 2020
Portfolio highlights
- Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
- Aino — Aino is a location intelligence tool that enables businesses to analyze spatial data in just minutes. Aino saves hundreds of hours on data work for real estate, retail, urban planning, and geo-marketing companies.
- Orbital Paradigm — Orbital Paradigm builds reusable vehicles that carry cargo to space and bring it back. Dedicated missions, any orbit, on your schedule. Based in Madrid.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 108
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 767
- Round size: Series A $9M–$116M; Series B $23M–$148M; Series C $19M–$160M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fresh fund, raised $192M in 2026
Portfolio highlights
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
- Bonovo Orthopedics —
The Techshop is a venture capital and private equity firm that invests in B2B digital startups.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, Portugal, Switzerland
Investor stats
- Total investments: 31
- Round size: Seed $2M–$8.1M; Pre-Seed $322k–$37M; Series A $7.7M–$120M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- SimpL — SimpL is an Italy-based AI sales-intelligence and prospecting platform for B2B sales teams. It researches target companies, identifies relevant buying signals, drafts personalised LinkedIn outreach, manages follow-ups, and helps generate qualified sales meetings.
- Computis — Computis is an AI company offering software solutions for electronic invoicing, bank reconciliation, tax estimation, and billing services.
- Helix Robotics — We are building the first commercial soft manipulator
Medical VC funding in Portugal at a glance
Stats across 81 deals from 65 investors.
Access all 65 VC funds in Portugal Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Portugal investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 65 VC funds investing in Portugal Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!